Recombinant Follicle Stimulating Hormone

PreclinicalSmall molecule

Recombinant Follicle Stimulating Hormone is one of 4 small molecule programs targeting Intrauterine Insemination. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Intrauterine InseminationUnknown status

Intrauterine InseminationPreclinical

Unknown status

Competition

Competitive Landscape

4 competitors in Intrauterine Insemination

#DrugCompanyPhaseTrials

REKOVELLE

Ferring

Phase 2

1 2

Micronized Progesterone

AAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Preclinical

1 3

Gnrha

SSecond Affiliated Hospital of Wenzhou Medical University

Preclinical

1 4

Recombinant Follicle Stimulating Hormone

OOrganon and Co

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Pregnancy2 trials

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)

Completed·OOrganon and Co··NCT00702338·1 enrolled

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)

Completed·OOrganon and Co··NCT00702520·15 enrolled

Embryo Transfer1 trial

Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI

Completed·—·Phase 4·NCT03118830·204 enrolled

Intrauterine Insemination1 trial

Comparison of Recombinant Follicle Stimulating Hormone and the Combination of Recombinant Follicle Stimulating Hormone With Clomiphene Citrate in Stimulated Intrauterine Insemination Cycles

Unknown status·—·N/A·NCT05670795·254 enrolled

Ovarian1 trial

Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS

Completed·UUniversity of California, San Diego·Phase 4·NCT03252223·33 enrolled

Ovarian Stimulation1 trial

Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation

Completed·NNational and Kapodistrian University of Athens·Phase 1/2·NCT01319695·140 enrolled

3 more indications

Infertility1 trial

A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)

Terminated·OOrganon and Co·Phase 2·NCT00697255·8 enrolled

Gene Polymorphism1 trial

Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)

Unknown status·IInstituto Bernabeu·Phase 4·NCT02625519·180 enrolled

Unspecified1 trial

Nordic Luveris Study

Completed·RRigshospitalet, Denmark·Phase 4·NCT00553293·526 enrolled

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for Recombinant Follicle Stimulating Hormone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Recombinant Follicle Stimulating Hormone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Recombinant Follicle Stimulating Hormone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Organon and Co company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: OOrganon and Co

Recombinant Follicle Stimulating Hormone

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Pregnancy2 trials

Embryo Transfer1 trial

Intrauterine Insemination1 trial

Ovarian1 trial

Ovarian Stimulation1 trial

Infertility1 trial

Gene Polymorphism1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News